A Phase II Multi-institutional Study Assessing Simultaneous In-field Boost Helical Tomotherapy for 1-3 Brain Metastases (TOMOSIBII)
A Phase II Multi-institutional Study Assessing Simultaneous In-Field Boost Helical Tomotherapy for 1-3 Brain Metastases
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
This PHASE2 trial investigates Metastasis to Brain of Primary Cancer and is currently completed. London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Apr 2025 — Present [monthly]
Completed PHASE2
-
Jan 2025 — Apr 2025 [monthly]
Completed PHASE2
-
Sep 2024 — Jan 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Ontario Institute for Cancer Research
For direct contact, visit the study record on ClinicalTrials.gov .